Company Filing History:
1 out of 987 
1 out of 1 Years Active: 2025
Title: Matthew Charles Tindall: Innovator in Nucleic Acid Technologies
Introduction
Matthew Charles Tindall is a notable inventor based in Piedmont, CA (US). He has made significant contributions to the field of nucleic acid technologies, particularly in the area of cell recognition and integration. His innovative work has the potential to impact the diagnosis and treatment of diseases, including cancer.
Latest Patents
Matthew Tindall holds 1 patent for his invention titled "Nucleic acids for cell recognition and integration." This patent provides nucleic acid sequences and delivery constructs that target and integrate into specific cells, such as diseased cells. The technology includes 'zip code' sequences that facilitate the delivery of nucleic acids across cellular membranes, allowing for targeted treatment options. The invention also encompasses methods for diagnosing and treating diseases using these specialized nucleic acid constructs.
Career Highlights
Throughout his career, Matthew Tindall has worked with esteemed institutions, including Emory University and Kodikaz Therapeutic Solutions, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Matthew has collaborated with Leon Bernal-Mizrachi, contributing to advancements in his research and development efforts.
Conclusion
Matthew Charles Tindall is a pioneering inventor whose work in nucleic acid technologies holds promise for improving medical treatments. His contributions to the field exemplify the impact of innovation on healthcare solutions.